摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3β-[(tri-O'-benzoyl-α-L-rhamnopyranosyl)oxy]-21-nitro-5β-pregnane-14β,20(R)-diol | 189102-09-8

中文名称
——
中文别名
——
英文名称
3β-[(tri-O'-benzoyl-α-L-rhamnopyranosyl)oxy]-21-nitro-5β-pregnane-14β,20(R)-diol
英文别名
——
3β-[(tri-O'-benzoyl-α-L-rhamnopyranosyl)oxy]-21-nitro-5β-pregnane-14β,20(R)-diol化学式
CAS
189102-09-8
化学式
C48H57NO12
mdl
——
分子量
839.98
InChiKey
OYDHMCWVEFXOPU-FWZUQCSFSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    7.2
  • 重原子数:
    61.0
  • 可旋转键数:
    11.0
  • 环数:
    8.0
  • sp3杂化的碳原子比例:
    0.56
  • 拓扑面积:
    180.96
  • 氢给体数:
    2.0
  • 氢受体数:
    12.0

反应信息

  • 作为反应物:
    描述:
    3β-[(tri-O'-benzoyl-α-L-rhamnopyranosyl)oxy]-21-nitro-5β-pregnane-14β,20(R)-diol甲醇4-二甲氨基吡啶乙酸酐 作用下, 以 乙醚 为溶剂, 反应 17.45h, 生成 20(R)-methoxy-21-nitro-3β-(α-L-rhamnopyranosyloxy)-5β-pregnan-14β-ol
    参考文献:
    名称:
    Synthesis and Structure−Activity Relationships of 17β-Substituted 14β-Hydroxysteroid 3-(α-l-Rhamnopyranoside)s:  Steroids That Bind to the Digitalis Receptor
    摘要:
    The preparation of 17 beta-substituted 14 beta-hydroxysteroid C-3 alpha-L-rhamnopyranosides is described. These derivatives have a 14 beta,20-ether, 14 beta,20-lactone, or 17 beta-CH2CH2OH, -CH2CH2NH2, -CH=CHNO2(E), -CH=CHCOOH(E), -CH(OH)CH2NO2(R), -CH(OMe)CH2NO2(R), -CH2CH2COOH, or -CH(OH)CH2NH2(R) group. Derivatives were assayed in a radioligand binding assay for [H-3]ouabain in membranes from canine heart muscle. The digitalis ''receptor'' comprises isoenzymes of the ion-pumping enzyme, Na+,K+-ATPase. The 17 beta-CH=CHNO2(E), 17 beta-CH=CHCOOH(E), and 17 beta-CH(OMe)CH2NO2(R) derivatives were the most potent and equivalent to ouabain with low-nanomolar IC50 values. The very potent binding affinity of the disubstituted compound 17 beta-CH(OMe)CH2NO2(R) further demonstrates that 17 beta-unsaturated substitution is not required for potent binding affinity. This observation may be of value in the separation of cardiotonic and cardiotoxic effects. Tosylation of the 17 beta-CH2OH, prepared from the 17 beta-CHO by lithium aluminum hydride reduction, yielded the 14 beta,17 beta-ether. Synthesis of the 17 beta-CH2COOH gave the epimeric 14 alpha,17 alpha- and 14 beta, 17 beta-lactones. Structures have been established by NMR analysis.
    DOI:
    10.1021/jm960880l
  • 作为产物:
    描述:
    硝基甲烷14-hydroxy-3β-<(tri-O-benzoyl-α-L-rhamnopyranosyl)oxy>-21-nor-5β,14β-pregnane-20-carboxaldehyde 在 potassium fluoride 作用下, 以 异丙醇 为溶剂, 反应 16.0h, 以38%的产率得到3β-[(tri-O'-benzoyl-α-L-rhamnopyranosyl)oxy]-21-nitro-5β-pregnane-14β,20(R)-diol
    参考文献:
    名称:
    Synthesis and Structure−Activity Relationships of 17β-Substituted 14β-Hydroxysteroid 3-(α-l-Rhamnopyranoside)s:  Steroids That Bind to the Digitalis Receptor
    摘要:
    The preparation of 17 beta-substituted 14 beta-hydroxysteroid C-3 alpha-L-rhamnopyranosides is described. These derivatives have a 14 beta,20-ether, 14 beta,20-lactone, or 17 beta-CH2CH2OH, -CH2CH2NH2, -CH=CHNO2(E), -CH=CHCOOH(E), -CH(OH)CH2NO2(R), -CH(OMe)CH2NO2(R), -CH2CH2COOH, or -CH(OH)CH2NH2(R) group. Derivatives were assayed in a radioligand binding assay for [H-3]ouabain in membranes from canine heart muscle. The digitalis ''receptor'' comprises isoenzymes of the ion-pumping enzyme, Na+,K+-ATPase. The 17 beta-CH=CHNO2(E), 17 beta-CH=CHCOOH(E), and 17 beta-CH(OMe)CH2NO2(R) derivatives were the most potent and equivalent to ouabain with low-nanomolar IC50 values. The very potent binding affinity of the disubstituted compound 17 beta-CH(OMe)CH2NO2(R) further demonstrates that 17 beta-unsaturated substitution is not required for potent binding affinity. This observation may be of value in the separation of cardiotonic and cardiotoxic effects. Tosylation of the 17 beta-CH2OH, prepared from the 17 beta-CHO by lithium aluminum hydride reduction, yielded the 14 beta,17 beta-ether. Synthesis of the 17 beta-CH2COOH gave the epimeric 14 alpha,17 alpha- and 14 beta, 17 beta-lactones. Structures have been established by NMR analysis.
    DOI:
    10.1021/jm960880l
点击查看最新优质反应信息

同类化合物

(5β)-17,20:20,21-双[亚甲基双(氧基)]孕烷-3-酮 (5α)-2′H-雄甾-2-烯并[3,2-c]吡唑-17-酮 (3β,20S)-4,4,20-三甲基-21-[[[三(异丙基)甲硅烷基]氧基]-孕烷-5-烯-3-醇-d6 (25S)-δ7-大发酸 (20R)-孕烯-4-烯-3,17,20-三醇 (11β,17β)-11-[4-({5-[(4,4,5,5,5-五氟戊基)磺酰基]戊基}氧基)苯基]雌二醇-1,3,5(10)-三烯-3,17-二醇 齐墩果酸衍生物1 黄麻属甙 黄芪皂苷III 黄芪皂苷 II 黄芪甲苷 IV 黄芪甲苷 黄肉楠碱 黄果茄甾醇 黄杨醇碱E 黄姜A 黄夹苷B 黄夹苷 黄夹次甙乙 黄夹次甙乙 黄夹次甙丙 黄体酮环20-(乙烯缩醛) 黄体酮杂质EPL 黄体酮杂质1 黄体酮杂质 黄体酮杂质 黄体酮EP杂质M 黄体酮EP杂质G(RRT≈2.53) 黄体酮EP杂质F 黄体酮6-半琥珀酸酯 黄体酮 17alpha-氢过氧化物 黄体酮 11-半琥珀酸酯 黄体酮 麦角甾醇葡萄糖苷 麦角甾醇氢琥珀酸盐 麦角甾烷-6-酮,2,3-环氧-22,23-二羟基-,(2b,3b,5a,22R,23R,24S)-(9CI) 麦角甾烷-3,6,8,15,16-五唑,28-[[2-O-(2,4-二-O-甲基-b-D-吡喃木糖基)-a-L-呋喃阿拉伯糖基]氧代]-,(3b,5a,6a,15b,16b,24x)-(9CI) 麦角甾烷-26-酸,5,6:24,25-二环氧-14,17,22-三羟基-1-羰基-,d-内酯,(5b,6b,14b,17a,22R,24S,25S)-(9CI) 麦角甾-8-烯-3-醇 麦角甾-8,24(28)-二烯-26-酸,7-羟基-4-甲基-3,11-二羰基-,(4a,5a,7b,25S)- 麦角甾-7,22-二烯-3-酮 麦角甾-7,22-二烯-17-醇-3-酮 麦角甾-5,24-二烯-26-酸,3-(b-D-吡喃葡萄糖氧基)-1,22,27-三羟基-,d-内酯,(1a,3b,22R)- 麦角甾-5,22,25-三烯-3-醇 麦角甾-4,6,8(14),22-四烯-3-酮 麦角甾-1,4-二烯-3-酮,7,24-二(乙酰氧基)-17,22-环氧-16,25-二羟基-,(7a,16b,22R)-(9CI) 麦角固醇 麦冬皂苷D 麦冬皂苷D 麦冬皂苷 B